Intended use
This hs-cTnI blood test is a rapid test to quantitatively detect the amount of hs-cTnI in mutiple blood samples from human. It is detected by LYOFIA® platform from VACURE Biotech.
It's for professional use only.
Summary
Cardiovascular disease is one of the leading causes of death from chronic diseases worldwide, and the global prevalence and mortality of cardiovascular disease are still on the rise. In the past 20-30 years, the number of patients with cardiovascular and cerebrovascular diseases has continued to increase.
Among cardiovascular diseases, acute coronary syndrome (ACS) has an acute onset and great harm (high morbidity, mortality, and disability rates), and its treatment effect depends largely on early diagnosis and treatment.
Cardiac troponin I (cTnI) is a special protein that only exists in myocardial cells and is currently recognized as the gold standard for reflecting myocardial necrosis. Under normal circumstances, the content of cTnI in peripheral blood is very small. When myocardial damage occurs, myocardial cells rupture, cTnI is released and flows into the peripheral blood with the circulating blood, and the cTnI content in peripheral blood increases. However, the traditional cTnI detection method is not sensitive enough, especially when the cTnI level in the blood circulation is low, the ischemic symptoms are mild, or the electrocardiogram changes are atypical, which can lead to misdiagnosis and missed diagnosis.
Why Test hs-cTnI?
Cardiac troponin (cTn) plays a core role in the early diagnosis and prognosis assessment of myocardial infarction and myocardial injury, and is the preferred marker for diagnosing myocardial infarction.
In recent years, with the progress of laboratory medicine, troponin has ushered in the "high-sensitivity era", which has greatly helped the clinical diagnosis and treatment of cardiovascular diseases.
- Early diagnosis of acute myocardial injury
Due to its more sensitive detection method, the application of hs-cTn can make the diagnosis of myocardial injury (including AMI) earlier. In the past, clinicians usually had to wait about 6 hours to observe a significant increase in cTn. Now, with the use of highly sensitive methods to detect cTn, it only takes 3 hours to detect an increase in cTn that is helpful for the clinical diagnosis of AMI.
- Used for risk stratification of diseases
Risk stratification of ACS prognosis, the result of hs-cTnI blood test can be more sensitive for ACS risk stratification. Many studies on cardiovascular patients, outpatients or community populations have found that the increase in hs-cTnI and the degree of increase are significantly related to subsequent cardiovascular events, and long-term continuous observation is more valuable; analyzing the detection value of cTn combined with the rate of change can help predict the long-term incidence or mortality of heart failure or cardiovascular events; hs-cTn detection values are relatively higher in the elderly and men.
Why Choose VACURE
- Accurate
L.od to 9pg/mL
- Fast
The hs-cTnI blood test detects hs-cTnI amout in 10minutes
- Easy
Simple work flow
Hot Tags: hs-cTnI Blood Test, China, suppliers, manufacturers, factory, pricelist, quotation
